Last reviewed · How we verify
NCT05502445
The Nutritionist's Educational Intervention on the Protein Intake in Hospitalized Elderly People
NA trial testing educational intervention in Old Age; Cachexia in 58 participants. Completed in 16 March 2022.
16 March 2022
Quick facts
| Lead sponsor | Hospital Israelita Albert Einstein |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 58 |
| Start date | 1 September 2021 |
| Primary completion | 16 March 2022 |
| Estimated completion | 16 March 2022 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- educational intervention
Conditions studied
- Old Age; Cachexia — all drugs for Old Age; Cachexia →
- Dietary Habits — all drugs for Dietary Habits →
- Sarcopenia — all drugs for Sarcopenia →
- Protein Malnutrition — all drugs for Protein Malnutrition →
Sponsor
Hospital Israelita Albert Einstein
Who can join
60 and older, any sex, with Old Age; Cachexia or Dietary Habits. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The food intake is often compromised in the elderly, and during hospitalization, dietary restrictions may be imposed, making them more susceptible to the risk of malnutrition and sarcopenia. It is essential to make an early identification of the elderly with low intake and involve them in their self-care. The aims will be assess the influence of the nutritionist's educational action to increase protein intake in elderly patients, to analyze the knowledge on its importance in the prevention of sarcopenia and to identify the prevalence of nutritional risk. This is a field, prospective, correlational, comparative and randomized study. The elderly patients will be randomized into a Control Group and Intervention Group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05502445
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of educational intervention
Trials testing the same drug.
- NCT06969482 — The Effect of Patient Advocacy Training on Advocacy Skills, Ethical Sensitivity, and Patient Safety Culture in Nurses · NA · not yet recruiting
- NCT05976477 — Reduction Of Dietary Salt Intake To Control Systolic Blood Pressure In Hypertensive Older Patients · NA · unknown
- NCT06323759 — Perinatal EDucation: Pedagogical Strategy and Facilitators for the PROMotion of BreastFeeding · NA · completed
- NCT05832957 — The Effectiveness of Cognitive-Functional Intervention to Reduce Driving Risk Factors of Adolescents With ADHD · NA · completed
- NCT05488743 — Smoking Prevention Program in Poland · unknown
Other Hospital Israelita Albert Einstein trials
Trials by the same sponsor.
- NCT07447674 — ED Post-Discharge Digital Follow-Up: A Communication Comparison · NA · not yet recruiting
- NCT07398222 — Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study · recruiting
- NCT07233837 — Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units · NA · recruiting
- NCT06726707 — COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis · Phase 2, PHASE3 · withdrawn
- NCT07112846 — Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05502445 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Israelita Albert Einstein
- Last refreshed: 16 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05502445.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing